Azista Bhutan - A Pharmaceutical Plant To Be Set Up In Samdrup Jongkhar In 2019
The ground-breaking ceremony for the construction of the pharmaceutical plant at Motanga Industrial Park was held on 17 May.
By Pema Seldon | Business Bhutan
Azista Bhutan Healthcare Limited (ABHL) will be setting up a full-fledged pharmaceutical plant. It will be located at Motanga Industrial Park, Samdrup Jongkhar. It plans to manufacture, package and distribute a wide range of prescription medicines under the brand Azista Bhutan.
The ground-breaking ceremony for the construction of the pharmaceutical plant at Motanga Industrial Park was held on 17 May and the facility would be the first of its kind in Bhutan. The total cost of the project is Nu 200mn.
Promoting Azista Bhutan in the international market
Given the rising demand for pharmaceutical products both in the local and international markets, and the fact that Bhutan has been importing all allopathic drugs from abroad, Druk Holding and Investments (DHI) took the initiative not only to curb imports but also to promote Brand Bhutan in a global market. This is achieved through the export of locally manufactured, quality pharmaceutical products.
According to a press release issued by DHI, it has been exploring investments in various business sectors, which has immense contributions toward the socio-economic development of the country.
“One such initiative is Azista Bhutan Healthcare Limited (ABHL), a joint venture company of Azista Industries Pvt. Ltd., India and Druk Holding & Investments Ltd,” the press release states.
Once operational, the company would be manufacturing, packaging and distributing 99 types of products under 17 major therapies. Besides meeting domestic demand for pharmaceutical products, the plant will also export to India and abroad.
Benefits of the project
The project is expected to bring lots of benefits to the economy in terms of foreign currency earnings from export, import of know-how but most importantly, it can provide employment opportunities.
The company is projected to employ 190 people in various occupational fields. In addition, local skill development for manufacturing pharmaceutical products would remain as the top priority of this project.
ABHL will eventually set up its own Research and Development (R & D) unit to improve the quality of its products and introduce a new range of goods in Bhutan and the overseas market.
Fostering a culture of innovation in Bhutan
This R&D initiative is expected to bring about much a much needed culture of innovation in Bhutan to meet social and commercial interest.
“Pharmaceutical as a clean industry is known for not generating any toxic and hazardous effluents. The state of the art technology that would be deployed for this project will ensure that the plant does not emit hazardous materials into the atmosphere,” the press release states.
ABHL is a project that is in compliance with the country’s developmental philosophy of Gross National Happiness.
The construction of the plant will start once the monsoon season is over and is expected to be completed in the second quarter of 2019.
This article first appeared in Business Bhutan and has been edited for the Bhutan Times.